BACKGROUND: We sought to determine the prevalence of abnormal pulmonary function tests (PFTs) in a cohort of children who had received whole lung irradiation (WLI) for treatment of metastatic disease. PROCEDURE: This was a retrospective (1988-2003) chart review that included all children treated at our institution with WLI who had undergone PFT. Data abstracted included oncologic diagnosis, radiation dose and fractionation, spirometry (FVC, FEV1, FEV1/FVC, FEF25%-75%), plethysmography (TLC, FRC, RV, RV/TLC), diffusing capacity (DLCO), and respiratory muscle strength (MIP, MEP). PFTs were normalized according to standard deviation (Z) scores. RESULTS: Thirty patients were identified who had one or more PFT. The incidence of mild, moderate, or severe reductions in FEV1 was 30%, 10%, and 10%, respectively, with 50% having normal FEV1. Seventeen percent of patients had mild reduction in total lung capacity (TLC), while 13% and 30% had moderate or severe reductions. Thirty-eight percent had mild reductions in diffusing capacity, while 29% and 14% had moderate or severe reductions. CONCLUSIONS: Pulmonary function abnormalities were common in this cohort of children treated with WLI, and may be progressive in nature. Further studies are warranted to identify patients at highest risk.
BACKGROUND: We sought to determine the prevalence of abnormal pulmonary function tests (PFTs) in a cohort of children who had received whole lung irradiation (WLI) for treatment of metastatic disease. PROCEDURE: This was a retrospective (1988-2003) chart review that included all children treated at our institution with WLI who had undergone PFT. Data abstracted included oncologic diagnosis, radiation dose and fractionation, spirometry (FVC, FEV1, FEV1/FVC, FEF25%-75%), plethysmography (TLC, FRC, RV, RV/TLC), diffusing capacity (DLCO), and respiratory muscle strength (MIP, MEP). PFTs were normalized according to standard deviation (Z) scores. RESULTS: Thirty patients were identified who had one or more PFT. The incidence of mild, moderate, or severe reductions in FEV1 was 30%, 10%, and 10%, respectively, with 50% having normal FEV1. Seventeen percent of patients had mild reduction in total lung capacity (TLC), while 13% and 30% had moderate or severe reductions. Thirty-eight percent had mild reductions in diffusing capacity, while 29% and 14% had moderate or severe reductions. CONCLUSIONS:Pulmonary function abnormalities were common in this cohort of children treated with WLI, and may be progressive in nature. Further studies are warranted to identify patients at highest risk.
Authors: Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness Journal: Phys Ther Date: 2009-01-15
Authors: Megan S Motosue; Liang Zhu; Kumar Srivastava; Dennis C Stokes; Melissa M Hudson; Valerie McPherson; Saumini Srinivasan; Matthew J Krasin; Daniel M Green; Sheri L Spunt; Hiroto Inaba Journal: Cancer Date: 2011-07-28 Impact factor: 6.860
Authors: Anne Stone; Danielle Novetsky Friedman; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Jessica Costello; Xian Wu; Nai-Kong Cheung; Charles A Sklar Journal: Pediatr Blood Cancer Date: 2019-08-12 Impact factor: 3.167
Authors: Gregory T Armstrong; Vijaya M Joshi; Liang Zhu; Deokumar Srivastava; Nan Zhang; Kirsten K Ness; Dennis C Stokes; Matthew T Krasin; James A Fowler; Leslie L Robison; Melissa M Hudson; Daniel M Green Journal: J Clin Oncol Date: 2013-01-07 Impact factor: 44.544
Authors: Anne Stone; Danielle Novetsky Friedman; Stefan Worgall; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Xian Wu; Nai-Kong Cheung; Charles A Sklar Journal: J Pediatr Hematol Oncol Date: 2017-10 Impact factor: 1.289
Authors: Tseng-Tien Huang; Melissa M Hudson; Dennis C Stokes; Matthew J Krasin; Sheri L Spunt; Kirsten K Ness Journal: Chest Date: 2011-03-17 Impact factor: 9.410
Authors: Chiaho Hua; Kelly A Hoth; Shengjie Wu; Larry E Kun; Monika L Metzger; Sheri L Spunt; Xiaoping Xiong; Mathew J Krasin Journal: Int J Radiat Oncol Biol Phys Date: 2010-01-07 Impact factor: 7.038
Authors: Daniel M Green; Jane M Lange; Annie Qu; Susan M Peterson; John A Kalapurakal; Dennis C Stokes; Yevgeny A Grigoriev; Janice R Takashima; Pat Norkool; Debra L Friedman; Norman E Breslow Journal: Pediatr Blood Cancer Date: 2013-06-14 Impact factor: 3.167